Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Compass Therapeutics, Inc. | 196,000 | reported | 29 Apr 2026 | tx 7+1,520,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Apr 2026 | GRANT_AWARD | Compass Therapeutics, Inc. | 25,000 | 1.89 USD | |
| 02 Jan 2026 | GRANT_AWARD | Compass Therapeutics, Inc. | 150,000 | 5.17 USD | |
| 02 Jan 2026 | GRANT_AWARD | Compass Therapeutics, Inc. | 720,000 | 0.00 USD | deriv |
| 07 Apr 2025 | PURCHASE | Compass Therapeutics, Inc. | 20,000 | 1.54 USD | |
| 11 Feb 2025 | GRANT_AWARD | Compass Therapeutics, Inc. | 280,000 | 0.00 USD | deriv |
| 13 Aug 2024 | GRANT_AWARD | Compass Therapeutics, Inc. | 300,000 | 0.00 USD | deriv |